Therefore, HBV-associated DLBCL is involved in the signaling pathways, including BCR, NF-κB, and JAK/STAT3, and further dysregulates oncogenes, including BCL-6, Myc, which are associated with poor prognosis. This evidence concerns the gene BCL6 and diffuse large B-cell lymphoma.